Deerfield Management’s Neuronetics STIM Stock Holding History

Deerfield Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-919,000	Closed	-$11.4M	–	156
2021 Q1	$11.4M	Hold	919,000	–	–	0.24%	94
2020 Q4	$10.2M	Sell	919,000 -656,000	-42%	-$4.93M	0.2%	105
2020 Q3	$7.66M	Sell	1,575,000 -118,317	-7%	-$449K	0.19%	90
2020 Q2	$3.27M	Buy	1,693,317 +118,317	+8%	+$243K	0.1%	87
2020 Q1	$2.98M	Buy	1,575,000 +500,000	+47%	+$1.56M	0.09%	81
2019 Q4	$4.83M	Buy	1,075,000 +735,488	+217%	+$4.57M	0.15%	64
2019 Q3	$2.82M	Buy	339,512 +180,512	+114%	+$1.97M	0.12%	82
2019 Q2	$1.99M	Hold	159,000	–	–	0.07%	91
2019 Q1	$2.42M	Hold	159,000	–	–	0.09%	84
2018 Q4	$3.08M	Buy	+159,000	New	+$3.49M	0.12%	81
2018 Q3	–	Sell	-125,000	Closed	-$3.33M	–	113
2018 Q2	$3.33M	Buy	+125,000	New	+$3.4M	0.12%	104

Other funds holding STIM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Deerfield Management's STIM Position: Q2 2021 in Review

Deerfield Management sold out of Neuronetics (STIM) in Q2 2021, closing a stake of 919,000 shares — an estimated $11.4M sold.

Deerfield Management first reported a position in STIM in Q2 2018 and held it in 11 quarters. The position peaked at $11.4M in Q1 2021. 105 funds tracked by Wall St. Rank hold STIM as of Q2 2021.

Deerfield Management reported no remaining Neuronetics position as of Q2 2021 after selling out during the quarter.
Deerfield Management sold 919,000 Neuronetics shares in Q2 2021, an estimated $11.4M.
Deerfield Management first reported a position in Neuronetics in Q2 2018 and held it in 11 quarters.
Deerfield Management's Neuronetics position peaked at $11.4M in Q1 2021.
105 funds tracked by Wall St. Rank held Neuronetics as of Q2 2021.

Based on Deerfield Management's 13F filing for Q2 2021, filed 16 Aug 2021.